Study provides scaffold to selectively target drug breakdown process

Scientists at St. Jude Children’s Research Hospital explored selectively blocking the CYP3A4 protein responsible for breaking down large swaths of approved drugs, providing a way to improve drug efficacy.

Continue Reading